Tag: kidney biopsy market size

  • Kidney Biopsy Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    Kidney Biopsy Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

    Discover trends, market shifts, and competitive outlooks for the kidney biopsy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    What Are the Key Milestones in the Kidney Biopsy Market’s Growth Trajectory From 2025 To 2034?

    In recent times, the market size for kidney biopsy has witnessed significant growth. The market, which was valued at $2.14 billion in 2024, is projected to grow to $2.27 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. The notable growth during the historic period can be linked to factors such as a rise in chronic kidney ailments, heightened public awareness about early diagnosis, an increase in the elderly population, expansion of healthcare infrastructure, increased governmental initiatives focusing on kidney disease management, and a surge in kidney health awareness.

    In the coming years, the kidney biopsy market is projected to experience robust growth. The market is set to escalate to $2.8 billion by 2029, with a compound annual growth rate (CAGR) of 5.4%. This growth during the forecast period is due to factors such as the rising incidence of kidney diseases, increased healthcare spending, heightened awareness of early diagnosis, growth in the elderly population, increased demand for minimally invasive procedures, and heightened research activities. The periods significant trends include advancements in biopsy technology, the shifting preference towards minimally invasive procedures, improvements in imaging technologies, utilizing artificial intelligence for superior accuracy, and cutting-edge innovations in biopsy devices.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

    What External and Internal Drivers Are Contributing to the Growth of the Kidney Biopsy Market?

    The kidney biopsy market is anticipated to experience substantial growth due to the increasing prevalence of renal cancer. This type of cancer is marked by the unregulated proliferation of abnormal cells in the kidney. The uptick in renal cancer incidences can be linked to lifestyle modifications, exposure to environmental toxins, and the improvement of detection techniques resulting in higher diagnosis rates. Kidney biopsies play a crucial role in diagnosing and managing renal cancer. They affirm the existence of cancerous cells, establish the grade of cancer, aid in devising treatment plans, track the response to treatment, and provide prognostic details. For example, Cancer Research UK, a renowned cancer research organization in the UK, anticipates that new kidney cancer cases will rise from roughly 16,300 in 2023 to about 21,900 in 2025. Consequently, the escalating incidence of renal cancer is fueling the expansion of the kidney biopsy market.

    Which Key Market Segments Comprise the Kidney Biopsy Market and Drive Its Revenue Growth?

    The kidney biopsy market covered in this report is segmented –

    1) By Type: Percutaneous Biopsy, Surgical Biopsy

    2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

    3) By End-User: Hospitals And Clinics, Urology Centers, Tertiary Care Centers, Other End-Users

    Subsegments:

    1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy, MRI-Guided Biopsy

    2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=16458&type=smp

    Which Geographic Areas Hold the Strongest Growth Potential in the Kidney Biopsy Market?

    North America was the largest region in the kidney biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Key Market Trends in the Kidney Biopsy Market Over the Coming Years?

    Leading businesses in the kidney biopsy market are leveraging artificial intelligence (AI) to create innovative platforms that boost diagnostic precision, refine procedures, and enhance patient results. AI augments kidney biopsy by refining image interpretation, offering diagnostic assistance, supporting treatment planning, providing predictive analytics, and propelling kidney disease research. For instance, in March 2024, a software firm based in the Netherlands, Aiosyn, introduced the NephroPath platform. This platform deploys computational pathology algorithms to scrutinize histological biomarkers in kidney biopsies, like identifying tissue types, calculating interstitial fibrosis, and accurately counting and evaluating glomeruli. Such an AI-based analysis guarantees uniform, thorough, and reproducible scoring of renal pathology biomarkers, bypassing the limitations of conventional scoring methods and observer bias.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

    How Is the Kidney Biopsy Market Conceptually Defined?

    A kidney biopsy, also known as a renal biopsy, is a medical procedure in which a small piece of kidney tissue is removed for microscopic examination. This procedure is typically performed to diagnose kidney conditions, assess the severity of known kidney diseases, or monitor the effectiveness of treatment. A kidney biopsy can help identify various kidney disorders, such as glomerulonephritis, interstitial nephritis, and nephrotic syndrome, and provide valuable information on the underlying causes of kidney dysfunction.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16458

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Key Insights into the Kidney Biopsy Market: Trends, Growth Rate, and Opportunities Through 2034

    Key Insights into the Kidney Biopsy Market: Trends, Growth Rate, and Opportunities Through 2034

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What External and Internal Drivers Are Contributing to the Growth of theKidney Biopsy Market?

    The kidney biopsy market is predicted to grow due to an increased prevalence of renal cancer. This type of cancer, defined by unregulated development of anomalous kidney cells, can be attributed to lifestyle transformations, exposure to environmental toxins, and improved detection methods leading to more diagnoses. A kidney biopsy is a crucial tool in the diagnosis and management of renal cancer. It verifies the existence of malignant cells and classifies the cancer grade. In addition, it aids in creating a treatment plan, monitoring its effectiveness, and offering prognosis-related information. For example, Cancer Research UK, a cancer research institution based in the UK, anticipates that new renal cancer cases will rise from roughly 16,300 in 2023 to an estimated 21,900 in 2025. Hence, the escalating occurrence of renal cancer is fuelling the expansion of the kidney biopsy market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

    #How Will the CAGR of the Kidney Biopsy Market Influence Its Overall Growth by 2034?

    In the past few years, the kidney biopsy market has seen significant growth. The market, which was valued at $2.14 billion in 2024, is projected to climb to $2.27 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.8%. The historical growth rate is attributed to a rise in chronic kidney diseases, an increase in consciousness about early diagnoses, a booming elderly population, expansion of the healthcare infrastructure, improved government-led initiatives for handling kidney diseases, and heightened awareness about renal health.

    Over the coming years, a significant surge is anticipated in the kidney biopsy market size, predicted to balloon to $2.8 billion by 2029, with an established compound annual growth rate (CAGR) of 5.4%. This projected expansion over the forecast period is linked to the growing incidence of kidney-related diseases, an increase in healthcare spending, heightened awareness for preventive early diagnosis, a burgeoning elderly population, and a growing preference for minimally invasive procedures, along with surges in research initiatives. Key trends during this forecast period encompass technological breakthroughs in biopsy procedures, a growing preference for minimally invasive processes, new developments in imaging technology, the incorporation of artificial intelligence for enhanced precision, and innovative changes in biopsy device technology.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16458

    Which Upcoming Market Trends and Innovations Are Set to Influence theKidney Biopsy Market’s Path Forward?

    Prominent businesses in the kidney biopsy market are making strides in innovation through the incorporation of artificial intelligence (AI) to heighten diagnostic precision, streamline protocols, and boost patient outcomes. AI plays a crucial role in strengthening kidney biopsy procedures through improved image interpretation, diagnostic assistance, help in devising treatment plans, predictive analysis provision, and fostering advancements in kidney disease research. For instance, the NephroPath platform was introduced in March 2024 by Aiosyn, a software company established in the Netherlands. By using computational pathology algorithms, the NephroPath platform can break down histological biomarkers in kidney biopsies—such activities include tissue type identification, interstitial fibrosis measurement, and precise glomeruli accounting and assessment. This AI-guided analysis maintains consistent, thorough, and repeatable scoring of renal pathology biomarkers, effectively addressing the limitations of traditional scoring methods and observer bias.

    Who Are the Dominant Market Players Pushing the Boundaries of theKidney Biopsy Market?

    Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

    What Are the Core Segments of the Kidney Biopsy Market, and How Do They Contribute to Growth?

    The kidney biopsy market covered in this report is segmented –

    1) By Type: Percutaneous Biopsy, Surgical Biopsy

    2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

    3) By End-User: Hospitals And Clinics, Urology Centers, Tertiary Care Centers, Other End-Users

    Subsegments:

    1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy, MRI-Guided Biopsy

    2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=16458&type=smp

    What Regions Are Dominating the Kidney Biopsy Market Growth?

    North America was the largest region in the kidney biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Kidney Biopsy Market 2025, By The Business Research Company:

    Diabetic Kidney Disease Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

    Kidney Disease Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

    Kidney Cancer Diagnostics And Therapeutics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Kidney Biopsy Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

    Kidney Biopsy Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

    Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

    What key factors are powering the surge in the kidney biopsy market right now?

    In recent times, the kidney biopsy market size has seen robust growth. From 2024 to 2025, it is predicted to grow from $2.14 billion to $2.27 billion, marking a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth during the historic period include an increase in chronic kidney diseases, growing awareness towards early diagnosis, a surge in the elderly population, advancement in healthcare infrastructure, improved government initiatives focused on kidney disease management, and heightened consciousness about kidney health.

    How fast Is the kidney biopsy market expected to grow, and what’s its future value?

    In the coming years, the kidney biopsy market size is projected to witness substantial growth, reaching $2.8 billion in 2029 with a compound annual growth rate (CAGR) of 5.4%. The growth in this period can be credited to factors such as the increasing prevalence of kidney related illnesses, escalating healthcare spending, growing consciousness about early diagnosis, growing elderly population, rising demand for procedures that are minimally invasive, as well as an increase in research activities. The forecast period is likely to see major trends such as enhancements in biopsy techniques, the adoption of minimally invasive procedures, advancements in imaging technologies, the incorporation of artificial intelligence for improved precision and technological innovations in biopsy tools.

    Get your kidney biopsy market report here!

    https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

    What are the leading drivers of growth in the kidney biopsy market?

    The kidney biopsy market is predicted to expand due to the mounting occurrence of renal cancer. Renal cancer, marked by the uncontrolled multiplication of anomalous cells in the kidney, has seen an increase due to factors such as lifestyle changes, environmental pollutants, and improved detection methods leading to more diagnoses. A kidney biopsy is crucial in diagnosing and managing renal cancer as it verifies the existence of malignant cells, determines the severity of cancer, helps plan the therapy, monitors the treatment progress, and offers prognosis data. For example, Cancer Research UK, a renowned cancer research institution, anticipates that new kidney cancer instances will rise from roughly 16,300 in 2023 to nearly 21,900 in 2025. Thus, the kidney biopsy market growth is being pushed by the rising incidence of renal cancer.

    What are the key segments defining the kidney biopsy market?

    The kidney biopsy market covered in this report is segmented –

    1) By Type: Percutaneous Biopsy, Surgical Biopsy

    2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

    3) By End-User: Hospitals And Clinics, Urology Centers, Tertiary Care Centers, Other End-Users

    Subsegments:

    1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy, MRI-Guided Biopsy

    2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

    Who are the key players steering the development of the kidney biopsy market?

    Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex

    What key trends are currently impacting the kidney biopsy market’s development?

    Prominent organizations functioning in the kidney biopsy market are creating novel frameworks through the incorporation of artificial intelligence (AI) to augment diagnostic precision, make procedures more efficient, and boost patient outcomes. By honing image analysis, extending diagnostic assistance, facilitating in procedure planning, providing predictive metrics, and fostering advancements in kidney disease research, AI elevates kidney biopsy procedures. For instance, Aiosyn, a software firm based in the Netherlands, introduced the NephroPath platform in March 2024. The NephroPath platform leverages computational pathology algorithms to examine histological biomarkers present in kidney biopsies, identify tissue types, exact measurement of interstitial fibrosis, and accurate counting and evaluation of glomeruli. This AI-powered analysis assures uniform, comprehensive, and repeatable scoring of renal pathology biomarkers, thus solving the issues associated with traditional scoring techniques and observer bias.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16458

    Which regions are most influential in expanding the kidney biopsy market?

    North America was the largest region in the kidney biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Diabetic Kidney Disease Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

    Kidney Disease Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

    Kidney Cancer Diagnostics And Therapeutics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Kidney Biopsy Market Forecast 2024-2033: Estimated Market Size And Growth Rate

    Global Kidney Biopsy Market Forecast 2024-2033: Estimated Market Size And Growth Rate

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Much Growth is Expected for the Kidney Biopsy Market from 2024 to 2033?

    The kidney biopsy market has shown strong growth, expected to increase from $2.03 billion in 2023 to $2.14 billion in 2024, with a CAGR of 5.3%. Growth factors include rising chronic kidney diseases, increased awareness of early diagnosis, a growing geriatric population, expanded healthcare infrastructure, and enhanced government initiatives for kidney disease management.

    The kidney biopsy market is expected to experience strong growth, reaching $2.66 billion by 2028 at a CAGR of 5.5%. Growth drivers include increasing kidney disease prevalence, rising healthcare spending, awareness of early diagnosis, a growing geriatric population, and demand for minimally invasive procedures. Major trends involve advancements in biopsy techniques, minimally invasive procedure adoption, imaging technology improvements, AI integration for precision, and innovations in biopsy devices.

    Claim Your Free Sample of the Global Kidney Biopsy Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

    What Factors Are Encouraging Growth in the Kidney Biopsy Market?

    The kidney biopsy market is likely to grow due to the rising incidence of renal cancer. This cancer type involves abnormal growth in kidney cells, with increasing diagnoses attributed to lifestyle changes and improved detection techniques. Kidney biopsies are crucial for diagnosing and managing renal cancer. Cancer Research UK projected new kidney cancer cases would rise from approximately 16,300 in 2023 to about 21,900 in 2025. Hence, the increasing incidence of renal cancer is driving the kidney biopsy market.

    Which Segments Play a Vital Role in the Kidney Biopsy Market?

    1) By Type: Percutaneous Biopsy, Surgical Biopsy

    2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

    3) By End-User: Hospitals And Clinics, Urology Centers, Tertiary Care Centers, Other End-Users

    What Trends Are Driving Change in the Kidney Biopsy Market?

    Firms in the kidney biopsy market are integrating artificial intelligence (AI) to enhance diagnostic accuracy and streamline procedures. In March 2024, Aiosyn launched the NephroPath platform, using AI to analyze kidney biopsy data and provide consistent, detailed evaluations.

    Order Now for Fast Delivery of Your Kidney Biopsy Market Report!

    https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

    What Regions Are Contributing Significantly to the Growth of the Kidney Biopsy Market?

    North America was the largest region in the kidney biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Kidney Biopsy Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the kidney biopsy market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Kidney Biopsy Market Include

    1. Kidney Biopsy Market Executive Summary

    2. Kidney Biopsy Market Segments

    3. Kidney Biopsy Market Size And Template Market Growth Rate

    4. Key Kidney Biopsy Market Trends

    5. Major Kidney Biopsy Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Kidney Biopsy Market

    26. Top Kidney Biopsy Companies

    27. Kidney Biopsy Market Opportunities And Strategies

    28. Kidney Biopsy Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Diabetic Kidney Disease Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

    Kidney Transplant Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

    Artificial Kidney Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-kidney-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Top 5 Insights From The Kidney Biopsy Market Report 2024

    Top 5 Insights From The Kidney Biopsy Market Report 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Kidney Biopsy Global Market Report 2024, the kidney biopsy market is expected to show promising growth in the forecast period.

    Market Growth and Projections

    • Current Market Size and Growth: The kidney biopsy market has experienced substantial growth, expanding from $2.03 billion in 2023 to $2.14 billion in 2024. This growth represents a compound annual growth rate (CAGR) of 5.3%.
    • Future Outlook: The market is projected to reach $2.66 billion by 2028, with a CAGR of 5.5%. Key drivers include an increase in kidney disease prevalence, rising healthcare expenditure, and heightened awareness about early diagnosis.

    Key Growth Drivers

    • Chronic Kidney Diseases: An increase in chronic kidney conditions is driving demand for biopsy procedures.
    • Awareness and Early Diagnosis: Greater awareness about kidney health and early diagnosis is contributing to market growth.
    • Aging Population: The surge in the geriatric population is leading to more cases of kidney diseases.
    • Healthcare Infrastructure: Expansion in healthcare infrastructure supports more widespread availability of biopsy procedures.
    • Government Initiatives: Enhanced government initiatives for kidney disease management are boosting market growth.

    View More On The Kidney Biopsy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

    Technological Advancements

    • Biopsy Techniques: Technological advancements are making biopsy techniques more effective and less invasive.
    • Imaging Technologies: Innovations in imaging are improving the precision of kidney biopsies.
    • Artificial Intelligence (AI): AI is enhancing diagnostic accuracy and streamlining procedures. For instance, Aiosyn’s NephroPath platform uses AI to analyze kidney biopsy histological biomarkers, improving consistency and detail in pathology assessments.

    Role of Kidney Biopsy in Renal Cancer Detection

    • Increased Renal Cancer Incidence: The rising incidence of renal cancer is a major driver for the kidney biopsy market. Factors include lifestyle changes, environmental toxins, and improved detection techniques.
    • Diagnostic and Management Benefits: Kidney biopsies are crucial for diagnosing renal cancer, determining cancer grade, planning treatment, monitoring response, and providing prognostic information. According to Cancer Research UK, new kidney cancer cases are expected to increase significantly by 2025, further driving the market.

    Major Companies and Market Players

    • Leading Companies: Major players include Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., and many others.
    • Acquisitions and Investments: Notable events include Halma plc’s acquisition of IZI Medical Products, which strengthens its position in the kidney biopsy sector and enhances the safety and accuracy of biopsy procedures.

    Market Segmentation

    • By Type: The market is divided into Percutaneous Biopsy and Surgical Biopsy.
    • By Indication: Key indications include Kidney Failure, Kidney Transplant, Hematuria, and Proteinuria.
    • By End-User: End-users comprise Hospitals and Clinics, Urology Centers, Tertiary Care Centers, and Other End-Users.

    Regional Insights

    • North America: The largest market for kidney biopsies in 2023.
    • Asia-Pacific: Expected to be the fastest-growing region in the forecast period due to increasing healthcare investments and growing patient populations.

    Conclusion
    The kidney biopsy market is on a strong growth trajectory, driven by advancements in technology, rising disease prevalence, and expanding healthcare infrastructure. The integration of AI and strategic acquisitions are poised to further enhance market dynamics, ensuring more accurate and efficient biopsy procedures in the future.

    Request A Sample Of The Global Kidney Biopsy Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=16458&type=smp